Clinical Trial Update: Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the hemodynamic effects of simvastatin in combination with beta blockers for portal hypertension associated with liver cirrhosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Liver Cirrhosis, Portal Hypertension. | Phase 4 | Status: UNKNOWN